000

SAILONG PHARMACEUT

No trades
See on Supercharts
Market capitalization
‪1.68 B‬CNY
−0.20CNY
‪−37.31 M‬CNY
‪259.20 M‬CNY
‪151.05 M‬
Beta (1Y)
1.44

About SAILONG PHARMACEUT

CEO
Chi Nong Cai
Headquarters
Zhuhai
Website
Employees (FY)
464
Founded
2002
ISIN
CNE1000032S5
FIGI
BBG00CMP7FV8
Sailong Pharmaceutical Group Co., Ltd. engages in the research, development, production, and marketing of pharmaceutical intermediates, raw materials, and preparations. It also offers related technical services. Its key products include thymofaxine for injection, argatroban injection and raw materials, tigecycline for injection and raw materials, monosialotetrahexose ganglioside sodium injection and raw materials, cerebroprotein hydrolysate for injection, milrinone injection, parecoxib sodium for injection and raw materials, tranexamic acid injection, clindamycin phosphate for injection, and pantoprazole sodium for injection. The company was founded by Nan Gui Cai on April 3, 2002 and is headquartered in Zhuhai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 002898 is 9.23 CNY — it has decreased by 2.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange SAILONG PHARMACEUT stocks are traded under the ticker 002898.
002898 stock is 3.72% volatile and has beta coefficient of 1.44. Check out the list of the most volatile stocks — is SAILONG PHARMACEUT there?
Yes, you can track SAILONG PHARMACEUT financials in yearly and quarterly reports right on TradingView.
002898 stock has fallen by 14.22% compared to the previous week, the month change is a 20.02% fall, over the last year SAILONG PHARMACEUT has showed a 9.78% decrease.
002898 net income for the last quarter is ‪1.34 M‬ CNY, while the quarter before that showed ‪−209.84 K‬ CNY of net income which accounts for 737.00% change. Track more SAILONG PHARMACEUT financial stats to get the full picture.
Today SAILONG PHARMACEUT has the market capitalization of ‪1.66 B‬, it has increased by 3.71% over the last week.
Like other stocks, 002898 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAILONG PHARMACEUT stock right from TradingView charts — choose your broker and connect to your account.
002898 reached its all-time high on Sep 27, 2017 with the price of 31.05 CNY, and its all-time low was 7.44 CNY and was reached on Feb 9, 2021.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 464.00 employees. See our rating of the largest employees — is SAILONG PHARMACEUT on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAILONG PHARMACEUT technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAILONG PHARMACEUT stock shows the strong sell signal. See more of SAILONG PHARMACEUT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.